[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Valsartan API Market Growth 2023-2029

February 2023 | 125 pages | ID: G02FF6D39D98EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Valsartan(CAS?137862-53-4) is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease.

LPI (LP Information)' newest research report, the “Valsartan API Industry Forecast” looks at past sales and reviews total world Valsartan API sales in 2022, providing a comprehensive analysis by region and market sector of projected Valsartan API sales for 2023 through 2029. With Valsartan API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Valsartan API industry.

This Insight Report provides a comprehensive analysis of the global Valsartan API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Valsartan API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Valsartan API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Valsartan API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Valsartan API.

The global Valsartan API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Valsartan API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Valsartan API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Valsartan API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Valsartan API players cover Biophore India Pharmaceuticals Pvt Ltd, Dr. Reddy's Laboratories, NEWEDGE Overseas, Suanfarma, Summit Pharmaceuticals Europe Srl, Octavius Pharma Pvt. Ltd, Synaptics Labs, Ami Lifesciences Private Limited and Zhuhai Rundu Pharmaceutical Co.,Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Valsartan API market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Above 98 %
  • Above 99 %
Segmentation by application
  • Tablets
  • Capsules
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Biophore India Pharmaceuticals Pvt Ltd
  • Dr. Reddy's Laboratories
  • NEWEDGE Overseas
  • Suanfarma
  • Summit Pharmaceuticals Europe Srl
  • Octavius Pharma Pvt. Ltd
  • Synaptics Labs
  • Ami Lifesciences Private Limited
  • Zhuhai Rundu Pharmaceutical Co.,Ltd
  • Zhejiang Tianyu Pharmaceutical
  • Menovo Pharmaceutical Co Ltd
  • Sun Pharma
  • Mylan
  • Cadila Pharmaceuticals
  • Mankind Pharma
  • Zhejiang Huahai Pharmaceutical
  • Ipca Laboratories
  • Zhejiang Hisun Pharmaceutical
  • DEAFARMA
  • CHEMO
  • Laurus Labs
Key Questions Addressed in this Report

What is the 10-year outlook for the global Valsartan API market?

What factors are driving Valsartan API market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Valsartan API market opportunities vary by end market size?

How does Valsartan API break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Valsartan API Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Valsartan API by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Valsartan API by Country/Region, 2018, 2022 & 2029
2.2 Valsartan API Segment by Type
  2.2.1 Above 98 %
  2.2.2 Above 99 %
2.3 Valsartan API Sales by Type
  2.3.1 Global Valsartan API Sales Market Share by Type (2018-2023)
  2.3.2 Global Valsartan API Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Valsartan API Sale Price by Type (2018-2023)
2.4 Valsartan API Segment by Application
  2.4.1 Tablets
  2.4.2 Capsules
  2.4.3 Others
2.5 Valsartan API Sales by Application
  2.5.1 Global Valsartan API Sale Market Share by Application (2018-2023)
  2.5.2 Global Valsartan API Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Valsartan API Sale Price by Application (2018-2023)

3 GLOBAL VALSARTAN API BY COMPANY

3.1 Global Valsartan API Breakdown Data by Company
  3.1.1 Global Valsartan API Annual Sales by Company (2018-2023)
  3.1.2 Global Valsartan API Sales Market Share by Company (2018-2023)
3.2 Global Valsartan API Annual Revenue by Company (2018-2023)
  3.2.1 Global Valsartan API Revenue by Company (2018-2023)
  3.2.2 Global Valsartan API Revenue Market Share by Company (2018-2023)
3.3 Global Valsartan API Sale Price by Company
3.4 Key Manufacturers Valsartan API Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Valsartan API Product Location Distribution
  3.4.2 Players Valsartan API Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR VALSARTAN API BY GEOGRAPHIC REGION

4.1 World Historic Valsartan API Market Size by Geographic Region (2018-2023)
  4.1.1 Global Valsartan API Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Valsartan API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Valsartan API Market Size by Country/Region (2018-2023)
  4.2.1 Global Valsartan API Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Valsartan API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Valsartan API Sales Growth
4.4 APAC Valsartan API Sales Growth
4.5 Europe Valsartan API Sales Growth
4.6 Middle East & Africa Valsartan API Sales Growth

5 AMERICAS

5.1 Americas Valsartan API Sales by Country
  5.1.1 Americas Valsartan API Sales by Country (2018-2023)
  5.1.2 Americas Valsartan API Revenue by Country (2018-2023)
5.2 Americas Valsartan API Sales by Type
5.3 Americas Valsartan API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Valsartan API Sales by Region
  6.1.1 APAC Valsartan API Sales by Region (2018-2023)
  6.1.2 APAC Valsartan API Revenue by Region (2018-2023)
6.2 APAC Valsartan API Sales by Type
6.3 APAC Valsartan API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Valsartan API by Country
  7.1.1 Europe Valsartan API Sales by Country (2018-2023)
  7.1.2 Europe Valsartan API Revenue by Country (2018-2023)
7.2 Europe Valsartan API Sales by Type
7.3 Europe Valsartan API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Valsartan API by Country
  8.1.1 Middle East & Africa Valsartan API Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Valsartan API Revenue by Country (2018-2023)
8.2 Middle East & Africa Valsartan API Sales by Type
8.3 Middle East & Africa Valsartan API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Valsartan API
10.3 Manufacturing Process Analysis of Valsartan API
10.4 Industry Chain Structure of Valsartan API

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Valsartan API Distributors
11.3 Valsartan API Customer

12 WORLD FORECAST REVIEW FOR VALSARTAN API BY GEOGRAPHIC REGION

12.1 Global Valsartan API Market Size Forecast by Region
  12.1.1 Global Valsartan API Forecast by Region (2024-2029)
  12.1.2 Global Valsartan API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Valsartan API Forecast by Type
12.7 Global Valsartan API Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Biophore India Pharmaceuticals Pvt Ltd
  13.1.1 Biophore India Pharmaceuticals Pvt Ltd Company Information
  13.1.2 Biophore India Pharmaceuticals Pvt Ltd Valsartan API Product Portfolios and Specifications
  13.1.3 Biophore India Pharmaceuticals Pvt Ltd Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Biophore India Pharmaceuticals Pvt Ltd Main Business Overview
  13.1.5 Biophore India Pharmaceuticals Pvt Ltd Latest Developments
13.2 Dr. Reddy's Laboratories
  13.2.1 Dr. Reddy's Laboratories Company Information
  13.2.2 Dr. Reddy's Laboratories Valsartan API Product Portfolios and Specifications
  13.2.3 Dr. Reddy's Laboratories Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Dr. Reddy's Laboratories Main Business Overview
  13.2.5 Dr. Reddy's Laboratories Latest Developments
13.3 NEWEDGE Overseas
  13.3.1 NEWEDGE Overseas Company Information
  13.3.2 NEWEDGE Overseas Valsartan API Product Portfolios and Specifications
  13.3.3 NEWEDGE Overseas Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 NEWEDGE Overseas Main Business Overview
  13.3.5 NEWEDGE Overseas Latest Developments
13.4 Suanfarma
  13.4.1 Suanfarma Company Information
  13.4.2 Suanfarma Valsartan API Product Portfolios and Specifications
  13.4.3 Suanfarma Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Suanfarma Main Business Overview
  13.4.5 Suanfarma Latest Developments
13.5 Summit Pharmaceuticals Europe Srl
  13.5.1 Summit Pharmaceuticals Europe Srl Company Information
  13.5.2 Summit Pharmaceuticals Europe Srl Valsartan API Product Portfolios and Specifications
  13.5.3 Summit Pharmaceuticals Europe Srl Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Summit Pharmaceuticals Europe Srl Main Business Overview
  13.5.5 Summit Pharmaceuticals Europe Srl Latest Developments
13.6 Octavius Pharma Pvt. Ltd
  13.6.1 Octavius Pharma Pvt. Ltd Company Information
  13.6.2 Octavius Pharma Pvt. Ltd Valsartan API Product Portfolios and Specifications
  13.6.3 Octavius Pharma Pvt. Ltd Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Octavius Pharma Pvt. Ltd Main Business Overview
  13.6.5 Octavius Pharma Pvt. Ltd Latest Developments
13.7 Synaptics Labs
  13.7.1 Synaptics Labs Company Information
  13.7.2 Synaptics Labs Valsartan API Product Portfolios and Specifications
  13.7.3 Synaptics Labs Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Synaptics Labs Main Business Overview
  13.7.5 Synaptics Labs Latest Developments
13.8 Ami Lifesciences Private Limited
  13.8.1 Ami Lifesciences Private Limited Company Information
  13.8.2 Ami Lifesciences Private Limited Valsartan API Product Portfolios and Specifications
  13.8.3 Ami Lifesciences Private Limited Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Ami Lifesciences Private Limited Main Business Overview
  13.8.5 Ami Lifesciences Private Limited Latest Developments
13.9 Zhuhai Rundu Pharmaceutical Co.,Ltd
  13.9.1 Zhuhai Rundu Pharmaceutical Co.,Ltd Company Information
  13.9.2 Zhuhai Rundu Pharmaceutical Co.,Ltd Valsartan API Product Portfolios and Specifications
  13.9.3 Zhuhai Rundu Pharmaceutical Co.,Ltd Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Zhuhai Rundu Pharmaceutical Co.,Ltd Main Business Overview
  13.9.5 Zhuhai Rundu Pharmaceutical Co.,Ltd Latest Developments
13.10 Zhejiang Tianyu Pharmaceutical
  13.10.1 Zhejiang Tianyu Pharmaceutical Company Information
  13.10.2 Zhejiang Tianyu Pharmaceutical Valsartan API Product Portfolios and Specifications
  13.10.3 Zhejiang Tianyu Pharmaceutical Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Zhejiang Tianyu Pharmaceutical Main Business Overview
  13.10.5 Zhejiang Tianyu Pharmaceutical Latest Developments
13.11 Menovo Pharmaceutical Co Ltd
  13.11.1 Menovo Pharmaceutical Co Ltd Company Information
  13.11.2 Menovo Pharmaceutical Co Ltd Valsartan API Product Portfolios and Specifications
  13.11.3 Menovo Pharmaceutical Co Ltd Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Menovo Pharmaceutical Co Ltd Main Business Overview
  13.11.5 Menovo Pharmaceutical Co Ltd Latest Developments
13.12 Sun Pharma
  13.12.1 Sun Pharma Company Information
  13.12.2 Sun Pharma Valsartan API Product Portfolios and Specifications
  13.12.3 Sun Pharma Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 Sun Pharma Main Business Overview
  13.12.5 Sun Pharma Latest Developments
13.13 Mylan
  13.13.1 Mylan Company Information
  13.13.2 Mylan Valsartan API Product Portfolios and Specifications
  13.13.3 Mylan Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.13.4 Mylan Main Business Overview
  13.13.5 Mylan Latest Developments
13.14 Cadila Pharmaceuticals
  13.14.1 Cadila Pharmaceuticals Company Information
  13.14.2 Cadila Pharmaceuticals Valsartan API Product Portfolios and Specifications
  13.14.3 Cadila Pharmaceuticals Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.14.4 Cadila Pharmaceuticals Main Business Overview
  13.14.5 Cadila Pharmaceuticals Latest Developments
13.15 Mankind Pharma
  13.15.1 Mankind Pharma Company Information
  13.15.2 Mankind Pharma Valsartan API Product Portfolios and Specifications
  13.15.3 Mankind Pharma Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.15.4 Mankind Pharma Main Business Overview
  13.15.5 Mankind Pharma Latest Developments
13.16 Zhejiang Huahai Pharmaceutical
  13.16.1 Zhejiang Huahai Pharmaceutical Company Information
  13.16.2 Zhejiang Huahai Pharmaceutical Valsartan API Product Portfolios and Specifications
  13.16.3 Zhejiang Huahai Pharmaceutical Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.16.4 Zhejiang Huahai Pharmaceutical Main Business Overview
  13.16.5 Zhejiang Huahai Pharmaceutical Latest Developments
13.17 Ipca Laboratories
  13.17.1 Ipca Laboratories Company Information
  13.17.2 Ipca Laboratories Valsartan API Product Portfolios and Specifications
  13.17.3 Ipca Laboratories Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.17.4 Ipca Laboratories Main Business Overview
  13.17.5 Ipca Laboratories Latest Developments
13.18 Zhejiang Hisun Pharmaceutical
  13.18.1 Zhejiang Hisun Pharmaceutical Company Information
  13.18.2 Zhejiang Hisun Pharmaceutical Valsartan API Product Portfolios and Specifications
  13.18.3 Zhejiang Hisun Pharmaceutical Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.18.4 Zhejiang Hisun Pharmaceutical Main Business Overview
  13.18.5 Zhejiang Hisun Pharmaceutical Latest Developments
13.19 DEAFARMA
  13.19.1 DEAFARMA Company Information
  13.19.2 DEAFARMA Valsartan API Product Portfolios and Specifications
  13.19.3 DEAFARMA Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.19.4 DEAFARMA Main Business Overview
  13.19.5 DEAFARMA Latest Developments
13.20 CHEMO
  13.20.1 CHEMO Company Information
  13.20.2 CHEMO Valsartan API Product Portfolios and Specifications
  13.20.3 CHEMO Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.20.4 CHEMO Main Business Overview
  13.20.5 CHEMO Latest Developments
13.21 Laurus Labs
  13.21.1 Laurus Labs Company Information
  13.21.2 Laurus Labs Valsartan API Product Portfolios and Specifications
  13.21.3 Laurus Labs Valsartan API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.21.4 Laurus Labs Main Business Overview
  13.21.5 Laurus Labs Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Valsartan API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Valsartan API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Above 98 %
Table 4. Major Players of Above 99 %
Table 5. Global Valsartan API Sales by Type (2018-2023) & (Kg)
Table 6. Global Valsartan API Sales Market Share by Type (2018-2023)
Table 7. Global Valsartan API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Valsartan API Revenue Market Share by Type (2018-2023)
Table 9. Global Valsartan API Sale Price by Type (2018-2023) & (US$/Kg)
Table 10. Global Valsartan API Sales by Application (2018-2023) & (Kg)
Table 11. Global Valsartan API Sales Market Share by Application (2018-2023)
Table 12. Global Valsartan API Revenue by Application (2018-2023)
Table 13. Global Valsartan API Revenue Market Share by Application (2018-2023)
Table 14. Global Valsartan API Sale Price by Application (2018-2023) & (US$/Kg)
Table 15. Global Valsartan API Sales by Company (2018-2023) & (Kg)
Table 16. Global Valsartan API Sales Market Share by Company (2018-2023)
Table 17. Global Valsartan API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Valsartan API Revenue Market Share by Company (2018-2023)
Table 19. Global Valsartan API Sale Price by Company (2018-2023) & (US$/Kg)
Table 20. Key Manufacturers Valsartan API Producing Area Distribution and Sales Area
Table 21. Players Valsartan API Products Offered
Table 22. Valsartan API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Valsartan API Sales by Geographic Region (2018-2023) & (Kg)
Table 26. Global Valsartan API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Valsartan API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Valsartan API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Valsartan API Sales by Country/Region (2018-2023) & (Kg)
Table 30. Global Valsartan API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Valsartan API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Valsartan API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Valsartan API Sales by Country (2018-2023) & (Kg)
Table 34. Americas Valsartan API Sales Market Share by Country (2018-2023)
Table 35. Americas Valsartan API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Valsartan API Revenue Market Share by Country (2018-2023)
Table 37. Americas Valsartan API Sales by Type (2018-2023) & (Kg)
Table 38. Americas Valsartan API Sales by Application (2018-2023) & (Kg)
Table 39. APAC Valsartan API Sales by Region (2018-2023) & (Kg)
Table 40. APAC Valsartan API Sales Market Share by Region (2018-2023)
Table 41. APAC Valsartan API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Valsartan API Revenue Market Share by Region (2018-2023)
Table 43. APAC Valsartan API Sales by Type (2018-2023) & (Kg)
Table 44. APAC Valsartan API Sales by Application (2018-2023) & (Kg)
Table 45. Europe Valsartan API Sales by Country (2018-2023) & (Kg)
Table 46. Europe Valsartan API Sales Market Share by Country (2018-2023)
Table 47. Europe Valsartan API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Valsartan API Revenue Market Share by Country (2018-2023)
Table 49. Europe Valsartan API Sales by Type (2018-2023) & (Kg)
Table 50. Europe Valsartan API Sales by Application (2018-2023) & (Kg)
Table 51. Middle East & Africa Valsartan API Sales by Country (2018-2023) & (Kg)
Table 52. Middle East & Africa Valsartan API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Valsartan API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Valsartan API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Valsartan API Sales by Type (2018-2023) & (Kg)
Table 56. Middle East & Africa Valsartan API Sales by Application (2018-2023) & (Kg)
Table 57. Key Market Drivers & Growth Opportunities of Valsartan API
Table 58. Key Market Challenges & Risks of Valsartan API
Table 59. Key Industry Trends of Valsartan API
Table 60. Valsartan API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Valsartan API Distributors List
Table 63. Valsartan API Customer List
Table 64. Global Valsartan API Sales Forecast by Region (2024-2029) & (Kg)
Table 65. Global Valsartan API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Valsartan API Sales Forecast by Country (2024-2029) & (Kg)
Table 67. Americas Valsartan API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Valsartan API Sales Forecast by Region (2024-2029) & (Kg)
Table 69. APAC Valsartan API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Valsartan API Sales Forecast by Country (2024-2029) & (Kg)
Table 71. Europe Valsartan API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Valsartan API Sales Forecast by Country (2024-2029) & (Kg)
Table 73. Middle East & Africa Valsartan API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Valsartan API Sales Forecast by Type (2024-2029) & (Kg)
Table 75. Global Valsartan API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Valsartan API Sales Forecast by Application (2024-2029) & (Kg)
Table 77. Global Valsartan API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Biophore India Pharmaceuticals Pvt Ltd Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 79. Biophore India Pharmaceuticals Pvt Ltd Valsartan API Product Portfolios and Specifications
Table 80. Biophore India Pharmaceuticals Pvt Ltd Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 81. Biophore India Pharmaceuticals Pvt Ltd Main Business
Table 82. Biophore India Pharmaceuticals Pvt Ltd Latest Developments
Table 83. Dr. Reddy's Laboratories Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 84. Dr. Reddy's Laboratories Valsartan API Product Portfolios and Specifications
Table 85. Dr. Reddy's Laboratories Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 86. Dr. Reddy's Laboratories Main Business
Table 87. Dr. Reddy's Laboratories Latest Developments
Table 88. NEWEDGE Overseas Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 89. NEWEDGE Overseas Valsartan API Product Portfolios and Specifications
Table 90. NEWEDGE Overseas Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 91. NEWEDGE Overseas Main Business
Table 92. NEWEDGE Overseas Latest Developments
Table 93. Suanfarma Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 94. Suanfarma Valsartan API Product Portfolios and Specifications
Table 95. Suanfarma Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 96. Suanfarma Main Business
Table 97. Suanfarma Latest Developments
Table 98. Summit Pharmaceuticals Europe Srl Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 99. Summit Pharmaceuticals Europe Srl Valsartan API Product Portfolios and Specifications
Table 100. Summit Pharmaceuticals Europe Srl Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 101. Summit Pharmaceuticals Europe Srl Main Business
Table 102. Summit Pharmaceuticals Europe Srl Latest Developments
Table 103. Octavius Pharma Pvt. Ltd Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 104. Octavius Pharma Pvt. Ltd Valsartan API Product Portfolios and Specifications
Table 105. Octavius Pharma Pvt. Ltd Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 106. Octavius Pharma Pvt. Ltd Main Business
Table 107. Octavius Pharma Pvt. Ltd Latest Developments
Table 108. Synaptics Labs Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 109. Synaptics Labs Valsartan API Product Portfolios and Specifications
Table 110. Synaptics Labs Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 111. Synaptics Labs Main Business
Table 112. Synaptics Labs Latest Developments
Table 113. Ami Lifesciences Private Limited Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 114. Ami Lifesciences Private Limited Valsartan API Product Portfolios and Specifications
Table 115. Ami Lifesciences Private Limited Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 116. Ami Lifesciences Private Limited Main Business
Table 117. Ami Lifesciences Private Limited Latest Developments
Table 118. Zhuhai Rundu Pharmaceutical Co.,Ltd Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 119. Zhuhai Rundu Pharmaceutical Co.,Ltd Valsartan API Product Portfolios and Specifications
Table 120. Zhuhai Rundu Pharmaceutical Co.,Ltd Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 121. Zhuhai Rundu Pharmaceutical Co.,Ltd Main Business
Table 122. Zhuhai Rundu Pharmaceutical Co.,Ltd Latest Developments
Table 123. Zhejiang Tianyu Pharmaceutical Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 124. Zhejiang Tianyu Pharmaceutical Valsartan API Product Portfolios and Specifications
Table 125. Zhejiang Tianyu Pharmaceutical Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 126. Zhejiang Tianyu Pharmaceutical Main Business
Table 127. Zhejiang Tianyu Pharmaceutical Latest Developments
Table 128. Menovo Pharmaceutical Co Ltd Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 129. Menovo Pharmaceutical Co Ltd Valsartan API Product Portfolios and Specifications
Table 130. Menovo Pharmaceutical Co Ltd Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 131. Menovo Pharmaceutical Co Ltd Main Business
Table 132. Menovo Pharmaceutical Co Ltd Latest Developments
Table 133. Sun Pharma Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 134. Sun Pharma Valsartan API Product Portfolios and Specifications
Table 135. Sun Pharma Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 136. Sun Pharma Main Business
Table 137. Sun Pharma Latest Developments
Table 138. Mylan Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 139. Mylan Valsartan API Product Portfolios and Specifications
Table 140. Mylan Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 141. Mylan Main Business
Table 142. Mylan Latest Developments
Table 143. Cadila Pharmaceuticals Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 144. Cadila Pharmaceuticals Valsartan API Product Portfolios and Specifications
Table 145. Cadila Pharmaceuticals Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 146. Cadila Pharmaceuticals Main Business
Table 147. Cadila Pharmaceuticals Latest Developments
Table 148. Mankind Pharma Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 149. Mankind Pharma Valsartan API Product Portfolios and Specifications
Table 150. Mankind Pharma Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 151. Mankind Pharma Main Business
Table 152. Mankind Pharma Latest Developments
Table 153. Zhejiang Huahai Pharmaceutical Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 154. Zhejiang Huahai Pharmaceutical Valsartan API Product Portfolios and Specifications
Table 155. Zhejiang Huahai Pharmaceutical Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 156. Zhejiang Huahai Pharmaceutical Main Business
Table 157. Zhejiang Huahai Pharmaceutical Latest Developments
Table 158. Ipca Laboratories Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 159. Ipca Laboratories Valsartan API Product Portfolios and Specifications
Table 160. Ipca Laboratories Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 161. Ipca Laboratories Main Business
Table 162. Ipca Laboratories Latest Developments
Table 163. Zhejiang Hisun Pharmaceutical Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 164. Zhejiang Hisun Pharmaceutical Valsartan API Product Portfolios and Specifications
Table 165. Zhejiang Hisun Pharmaceutical Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 166. Zhejiang Hisun Pharmaceutical Main Business
Table 167. Zhejiang Hisun Pharmaceutical Latest Developments
Table 168. DEAFARMA Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 169. DEAFARMA Valsartan API Product Portfolios and Specifications
Table 170. DEAFARMA Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 171. DEAFARMA Main Business
Table 172. DEAFARMA Latest Developments
Table 173. CHEMO Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 174. CHEMO Valsartan API Product Portfolios and Specifications
Table 175. CHEMO Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 176. CHEMO Main Business
Table 177. CHEMO Latest Developments
Table 178. Laurus Labs Basic Information, Valsartan API Manufacturing Base, Sales Area and Its Competitors
Table 179. Laurus Labs Valsartan API Product Portfolios and Specifications
Table 180. Laurus Labs Valsartan API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 181. Laurus Labs Main Business
Table 182. Laurus Labs Latest Developments

LIST OF FIGURES

Figure 1. Picture of Valsartan API
Figure 2. Valsartan API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Valsartan API Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Valsartan API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Valsartan API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Above 98 %
Figure 10. Product Picture of Above 99 %
Figure 11. Global Valsartan API Sales Market Share by Type in 2022
Figure 12. Global Valsartan API Revenue Market Share by Type (2018-2023)
Figure 13. Valsartan API Consumed in Tablets
Figure 14. Global Valsartan API Market: Tablets (2018-2023) & (Kg)
Figure 15. Valsartan API Consumed in Capsules
Figure 16. Global Valsartan API Market: Capsules (2018-2023) & (Kg)
Figure 17. Valsartan API Consumed in Others
Figure 18. Global Valsartan API Market: Others (2018-2023) & (Kg)
Figure 19. Global Valsartan API Sales Market Share by Application (2022)
Figure 20. Global Valsartan API Revenue Market Share by Application in 2022
Figure 21. Valsartan API Sales Market by Company in 2022 (Kg)
Figure 22. Global Valsartan API Sales Market Share by Company in 2022
Figure 23. Valsartan API Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Valsartan API Revenue Market Share by Company in 2022
Figure 25. Global Valsartan API Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Valsartan API Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Valsartan API Sales 2018-2023 (Kg)
Figure 28. Americas Valsartan API Revenue 2018-2023 ($ Millions)
Figure 29. APAC Valsartan API Sales 2018-2023 (Kg)
Figure 30. APAC Valsartan API Revenue 2018-2023 ($ Millions)
Figure 31. Europe Valsartan API Sales 2018-2023 (Kg)
Figure 32. Europe Valsartan API Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Valsartan API Sales 2018-2023 (Kg)
Figure 34. Middle East & Africa Valsartan API Revenue 2018-2023 ($ Millions)
Figure 35. Americas Valsartan API Sales Market Share by Country in 2022
Figure 36. Americas Valsartan API Revenue Market Share by Country in 2022
Figure 37. Americas Valsartan API Sales Market Share by Type (2018-2023)
Figure 38. Americas Valsartan API Sales Market Share by Application (2018-2023)
Figure 39. United States Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Valsartan API Sales Market Share by Region in 2022
Figure 44. APAC Valsartan API Revenue Market Share by Regions in 2022
Figure 45. APAC Valsartan API Sales Market Share by Type (2018-2023)
Figure 46. APAC Valsartan API Sales Market Share by Application (2018-2023)
Figure 47. China Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Valsartan API Sales Market Share by Country in 2022
Figure 55. Europe Valsartan API Revenue Market Share by Country in 2022
Figure 56. Europe Valsartan API Sales Market Share by Type (2018-2023)
Figure 57. Europe Valsartan API Sales Market Share by Application (2018-2023)
Figure 58. Germany Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Valsartan API Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Valsartan API Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Valsartan API Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Valsartan API Sales Market Share by Application (2018-2023)
Figure 67. Egypt Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Valsartan API Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Valsartan API in 2022
Figure 73. Manufacturing Process Analysis of Valsartan API
Figure 74. Industry Chain Structure of Valsartan API
Figure 75. Channels of Distribution
Figure 76. Global Valsartan API Sales Market Forecast by Region (2024-2029)
Figure 77. Global Valsartan API Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Valsartan API Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Valsartan API Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Valsartan API Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Valsartan API Revenue Market Share Forecast by Application (2024-2029)


More Publications